Enfusion Continues To Expect FY24 GAAP Revenues Of $200M - $210M, Est $205.565M
Portfolio Pulse from Benzinga Newsdesk
Enfusion continues to expect FY24 GAAP revenues of $200M - $210M, aligning with the estimated $205.565M.
August 06, 2024 | 11:48 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Enfusion continues to expect FY24 GAAP revenues of $200M - $210M, aligning with the estimated $205.565M.
Enfusion's revenue expectations for FY24 are in line with market estimates, which is likely to be viewed positively by investors, potentially leading to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100